SciELO - Scientific Electronic Library Online

 
vol.129 número1Tratamiento de la insuficiencia cardíaca avanzada mediante trasplante de corazónInstrumento de evaluación funcional de la discapacidad en rehabilitación.: Estudio de confiabilidad y experiencia clínic a con el uso del Functional Independence Measure índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

VEGA R, Inés et al. Hepatitis C virus in a group of hematological and oncohematological patients. Rev. méd. Chile [online]. 2001, vol.129, n.1, pp.18-22. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872001000100003.

Background: Little information is available in Chile about hepatitis C virus (HCV) in hematological and oncohematological patients. Aim: To evaluate the prevalence of hepatitis C virus markers in a group of hematological and oncohematological pediatric patients seen at Valdivia Regional Hospital. Patients and methods: Antibodies against virus C, determined by ELISA and viral RNA, determined using RT-polymerase chain reaction, were measured in 54 blood samples from children with hematological diseases (34 with Acute Lymphoblastic Leukaemia, 4 with Hodgkin Diseases, 4 with Haemolytic Anemia, 5 with Sarcomas, 2 with Non-Hodgkin Lymphoma, 2 with Thrombocytopenic Purpura, 1 with an Ependimoma, one with a Wilms Tumor and 1 with a Von Willebrand Disease). Results: All samples were negative for antibodies against hepatitis C virus. Viral RNA was found in four children, all with a diagnosis of acute lymphoblastic leukemia and who received chemotherapy and multiple transfusions. Conclusions: The prevalence of Viral RNA for hepatitis C virus in oncohematological patients in our study is high and associated with the use of chemotherapy and multiple transfusions (Rev Méd Chile 2001; 129: 18-22)

Palavras-chave : Hematologic diseases; Hepatitis C; Hepatitis C antibodies; Polymerase chain reaction.

        · texto em Espanhol

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons